Shares of STERIS plc (NYSE:STE – Get Free Report) have received an average recommendation of “Moderate Buy” from the six ratings firms that are presently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $276.33.
Several analysts have recently weighed in on STE shares. UBS Group cut their price objective on STERIS from $275.00 to $270.00 and set a “buy” rating for the company in a report on Friday, August 7th. Jefferies Financial Group raised STERIS from a “hold” rating to a “buy” rating in a research note on Friday. Morgan Stanley raised STERIS from an “overweight” rating to a “buy” rating in a report on Friday. Wall Street Zen cut shares of STERIS from a “strong-buy” rating to a “buy” rating in a research report on Sunday, October 11th. Finally, KeyCorp upped their price target on shares of STERIS from $269.00 to $284.00 and gave the company an “overweight” rating in a report on Friday, November 6th.
Check Out Our Latest Analysis on STE
STERIS Price Performance
Shares of NYSE:STE opened at $253.50 on Friday. The stock has a market cap of $24.62 billion, a price-to-earnings ratio of 30.07 and a beta of 0.86. The company has a debt-to-equity ratio of 0.23, a current ratio of 2.05 and a quick ratio of 1.44. STERIS has a 12 month low of $195.14 and a 12 month high of $269.44. The stock’s 50 day moving average price is $222.55 and its 200 day moving average price is $224.61.
STERIS (NYSE:STE – Get Free Report) last issued its quarterly earnings results on Wednesday, November 4th. The medical equipment provider reported $2.94 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.68 by $0.26. STERIS had a return on equity of 14.80% and a net margin of 13.41%. The firm had revenue of $1.59 billion during the quarter, compared to analyst estimates of $1.56 billion. During the same period last year, the company posted $2.47 EPS. The firm’s quarterly revenue was up 8.8% on a year-over-year basis. Equities research analysts anticipate that STERIS will post 11.46 earnings per share for the current fiscal year.
STERIS Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 17th. Stockholders of record on Tuesday, November 17th will be paid a $0.69 dividend. The ex-dividend date of this dividend is Tuesday, November 17th. This represents a $2.76 annualized dividend and a dividend yield of 1.1%. STERIS’s payout ratio is currently 32.74%.
Insider Buying and Selling
In related news, Director Mohsen Sohi sold 4,893 shares of the stock in a transaction that occurred on Tuesday, November 10th. The shares were sold at an average price of $253.22, for a total transaction of $1,239,005.46. Following the completion of the sale, the director directly owned 24,305 shares of the company’s stock, valued at $6,154,512.10. This represents a 16.76% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Karen Burton sold 5,880 shares of the stock in a transaction that occurred on Wednesday, November 11th. The shares were sold at an average price of $255.62, for a total transaction of $1,503,045.60. Following the sale, the chief financial officer directly owned 12,956 shares of the company’s stock, valued at approximately $3,311,812.72. This represents a 31.22% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 1.12% of the stock is owned by insiders.
Institutional Investors Weigh In On STERIS
Several large investors have recently modified their holdings of STE. NewEdge Advisors LLC raised its position in shares of STERIS by 0.7% during the second quarter. NewEdge Advisors LLC now owns 8,118 shares of the medical equipment provider’s stock worth $1,710,000 after purchasing an additional 56 shares during the period. Taylor Frigon Capital Management LLC lifted its holdings in shares of STERIS by 0.9% during the third quarter. Taylor Frigon Capital Management LLC now owns 6,505 shares of the medical equipment provider’s stock valued at $1,366,000 after purchasing an additional 58 shares during the last quarter. Strengthening Families & Communities LLC lifted its holdings in shares of STERIS by 0.6% during the third quarter. Strengthening Families & Communities LLC now owns 10,884 shares of the medical equipment provider’s stock valued at $2,286,000 after purchasing an additional 61 shares during the last quarter. Mather Group LLC. boosted its position in shares of STERIS by 14.4% in the 3rd quarter. Mather Group LLC. now owns 565 shares of the medical equipment provider’s stock valued at $119,000 after purchasing an additional 71 shares during the period. Finally, Community Financial Services Group LLC boosted its position in shares of STERIS by 50.0% in the 3rd quarter. Community Financial Services Group LLC now owns 216 shares of the medical equipment provider’s stock valued at $45,000 after purchasing an additional 72 shares during the period. 94.69% of the stock is owned by institutional investors.
STERIS Company Profile
STERIS plc (NYSE: STE) provides infection prevention and procedural products and services for healthcare, pharmaceutical, research, and other industries. Its offerings include sterilizers, washers and other equipment used to clean and sterilize medical devices and surgical instruments, as well as products for operating rooms and endoscopy procedures. The company also provides equipment installation, maintenance, repair, and training, along with contract sterilization and laboratory testing services.
Featured Stories
- Five stocks we like better than STERIS
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.
